| Name | Cobitolimod sodium |
|---|
| Description | Cobitolimod sodium is a DNA oligonucleotide agonist of TLR-9 with anti-inflammatory activity. Cobitolimod sodium inhibits Th17 cells and induces anti-inflammatory FoxP3 and IL-10 expression, inhibiting the IL-17 signaling pathway[1]. |
|---|---|
| Related Catalog | |
| Target |
TLR-9[1] |
| References |
| Molecular Formula | C185H215N73O105P18S6Na18 |
|---|---|
| Molecular Weight | 6320.80 |